SBWire

Global Market Direct's pharmaceuticals report, "NsGene A/S - Product Pipeline Review - 2012" provides data on the NsGene A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Colby Pharmaceutical Company - Product Pipeline Review - 2012" provides data on the Colby Pharmaceutical Company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Anemia. Chemotherapy Induced Anemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Published by Canadean, the Global Carbonated Report 2012 provides a detailed analysis of the carbonated soft drinks market, with global, regional and individual country data including forecasts to 2015.

Provides in-depth analysis of the latest trends in online consumer shopping, covering drivers of online shopping, consumer insights, market dynamics (covering 25 product categories) and reviews of the latest best practice in online retail site design- Based on the latest data, the report not only provides details of the size and growth of this increasingly important channel, it also provides essential contenton the penetration of online sales by product groups, how growth has developed over time, and key drivers of this market in the future

GBI Research's report, "Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand" provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations' (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

This report gives a view of the country's thermal energy market and provides forecasts to 2020. This report includes information on thermal (coal, oil and gas) installed capacity and generation. It provides information on key trends, profiles of major industry participants, information on major power plants and analysis of important deals. This along with detailed information on the regulatory framework and key policies governing the industry, provides a comprehensive understanding of the market for thermal power in the country. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Market Direct's pharmaceuticals report, "iCeutica, Inc. - Product Pipeline Review - 2012" provides data on the iCeutica, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "ViroMed Co., Ltd. - Product Pipeline Review - 2012" provides data on the ViroMed Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Congenital Heart Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Congenital Heart Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Congenital Heart Disease. Congenital Heart Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

"Poland Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2018", a new report by Global Markets Direct, provides key market data on the Poland Diagnostic Imaging market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Global Market Direct's pharmaceuticals report, "Kowa Company, Ltd. - Product Pipeline Review - 2012" provides data on the Kowa Company, Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Avexa Limited - Product Pipeline Review - 2012" provides data on the Avexa Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

SP Industries, a leader in the manufacturing of waste handling and material handling equipment, has announced that representatives of the company will be attending the 2013 Institute of Scrap Recycling Industries (ISRI) Convention. The Convention will take place from April 9th to the 13th in Orlando, Florida and will feature speakers such as Tom Brokaw, Pennsylvania Governor Ed Rendell, and Dara Torres.

BMI View: Compared to its European peers Germany's construction industry looks strong, but the eurozone crisis still threatens confidence in the sector. Construction industry value is expected to reach US$132.4bn for 2012, with year-on-year (y-o-y) growth of just 1.35%. A period of low growth is expected to continue throughout our 10-year forecast period, with annual average growth of 0.84% anticipated between 2012 and 2021, with industry value due to reach US$160.2bn by the end of this period.

The US is the largest wealth market in the world, accounting for 32% of the total number of worldwide UHNWIs in 2011. This report reviews the performance and asset allocations of UHNWIs in the US and highlights the top performing cities. It also includes an evaluation of the local wealth management industry.

BMI's Venezuela Petrochemicals Report examines the enormous long-term potential of the local petrochemicals industry, but flags concerns about the impact of government policy on investment. The report examines the strengths and weaknesses of the Venezuelan petrochemicals industry and how producers are minimising investment risk. The report also analyses the growth and risk management strategies being employed by the leading players in the sector, as they seek to maximise the tremendous growth opportunities offered by local oil and gas reserves.

The US Petrochemicals Report examines the short-term trends in domestic consumption and production growth amid a simultaneous economic slowdown and surge in investment in capacity based on ethane from the Marcellus shale gas reserves.

Following relatively flat growth in vehicle sales of 0.36% in 2011, BMI expects a slightly higher level of growth for the sector in 2012 at around 2.1%. The lack of vehicle production in Hong Kong means that the market's potential for expansion is limited. Nonetheless, the parts sector remains buoyant, as sales of automotive components were up 5.9% y-o-y in July 2012 as a result of rising demand.

BMI's Q412 Southern Africa report analyses latest industry, regulatory and macroeconomic developments in the telecoms markets of seven countries: Angola, Botswana, Mozambique, Mauritius, Namibia, Zambia and Zimbabwe. It also contains analysis of latest market data relating to the end of Q212 and updated five-year forecasts, through to 2016, for the mobile, fixed-line and internet sectors.

The Singapore Insurance Report considers the prospects for life and non-life insurers in the country. In world terms, Singapore ranks as a medium-sized market for (re) insurance that, in spite of being well developed by most metrics, will likely to grow quite rapidly through the forecast period. There are essentially three components to the sector. The first is a mature domestic non-life business - the Singapore insurance funds - in which premiums are growing at single digit rates. The second is a rapidly developing offshore non-life (re)insurance business. The non-life (re) insurers who are operating in/through Singapore are significant beneficiaries of the overall economic growth of South East Asia. The third is the dynamic life insurance segment, which has much in common with its counterpart in Hong Kong.

BMI View: Hong Kong's telecommunications market, particularly the mobile sector, is one of the most dynamic and mature in the Asia Pacific region. Five mobile operators and 11 mobile virtual network operators ensures strong competition, attractive tariff rates for the territory's consumers, and constant network upgrades and expansions. The introduction of LTE services should provide another round of revenue growth opportunities such as high-definition mobile TV services for operators, although fixed services such as fibre broadband remains key given the territory's position as a vital financial hub.

Bluelineproducts.com creates war against exhaustion by offering a Special Boost of Energy. The Energy Boosting Combo is available at an unbeatable discount for a limited time. The potent combo is helpful for correcting and increasing the function of Adrenal Glands and to boost energy levels. The Advantage Adrenal formula contains an all-natural blend of herbs that balances, supports, and rebuilds the adrenal glands. The unique herbal combination of Advantage Adrenal Formula are specially designed to provide various functions to improve mental focus and memory; relieve from stress and anxiety; relax the nerves, and to rebuild the nervous system. This formula contains important nutrients, minerals and plant vitamins that help to sustain the adrenal components, stabilize the function of the autonomic nervous system, and contribute to an overall state of wellness.

Two months ago it was concluded that the recruitment of Norwegian Xocai distributors had increased by 103%, from about 75 new Norwegian distributors per week to about 158. The effect of the massive positive media attention this summer therefore had a tremendous impact on the further spread of the "Healthy Chocolate" concept and it looks like this trend also spread internationally. Since 2008, the recruitment pace has been increased by 2/3 on a global scale and this year in particular has been a historical high for the company with over 11,220 new distributors enlisted.

Diet Doc has launched My Diet Doc Health Questionnaire that offers symptom-based results for fast weight loss. This tool conducts a detailed and subjective review of all the organ systems in the patient’s body to determine the factors that are hindering their health. This free online and comprehensive health questionnaire assesses the strengths and weaknesses of the Digestive system, Liver and kidneys, Metabolism including thyroid, Blood sugar, Heart, Brain function: memory/mood, Immune system, lungs, urological, sexual, and musculoskeletal systems. Worth $200, it is offered for free to all the new patients who sign up for their prescription hCG weight loss diet. To address the problem, it also suggests the most suitable supplements that are may lead to restored health and wellbeing.